Studies have shown that Sp1 can directly bind to the promoter region of the PCK1 [22] and controls the proliferation of breast cancer cells by interacting with insulin-like growth factors I receptor [23], enhancing their transcriptional activity. Here, IGF1R is linked to breast cancer.